Physician

Ahmad Abu Homoud

According to 2025 Medicare claims, Ahmad Homoud (NPI: 1568872273) practices pulmonary disease in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is SHORE PULMONARY, PA (NPI: 1053382499; TIN: 222348720) and primary practice location at 07753-4859.

Homoud's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 998 traditional Medicare patients, billed 2,614 HCPCS/CPT codes, and received $209,745 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,657 prescription claims across 313 beneficiaries totaling $1,687,530 in drug costs, led by Tyvaso Dpi (Treprostinil). DME data shows 1,282 claims. Open Payments data shows 94 records totaling $19,765. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,583 to $1,687,530. For DME billing, reported payments moved sharply higher in recent years, from $1,181 to $80,555.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	597	2,181	$193,483
2021	1,002	3,545	$267,994
2022	1,111	3,070	$261,382
2023	1,060	2,920	$238,343
2024	998	2,614	$209,745

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	12	$1,583
2018	14	50	$4,005
2019	33	173	$27,580
2020	26	122	$29,507
2021	86	178	$49,828
2022	180	585	$563,653
2023	243	1,281	$1,164,648
2024	313	1,657	$1,687,530

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	28	$1,129
2021	23	118	$5,119
2022	61	466	$78,339
2023	191	820	$130,705
2024	374	1,282	$118,354

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	290	298	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	170	262	$99
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	190	397	$94
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	309	463	$61
94010	Test to measure expiratory airflow and volume	152	235	$21

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tyvaso Dpi	Treprostinil	15	420	$349,379
Dupixent Pen	Dupilumab	65	2,058	$267,817
Ofev	Nintedanib Esylate	15	510	$221,203
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	221	9,210	$190,697
Prolastin C	Alpha-1-Proteinase Inhibitor	11	287	$121,805

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	42	$39,183
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	49	$37,324
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	18	144	$9,380
E1392	Portable oxygen concentrator, rental	Y	16	136	$4,430
E0601	Continuous positive airway pressure (cpap) device	Y	27	146	$4,130

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	94	$19,765	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Abu Homoud?

Tedicare shows public-source Medicare data for Ahmad Abu Homoud (NPI 1568872273), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Abu Homoud have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmad Abu Homoud?

Ahmad Abu Homoud is linked to SHORE PULMONARY, PA (billing NPI 1053382499) in the available physician profile data.

Does Ahmad Abu Homoud have Open Payments data?

Ahmad Abu Homoud has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.